BI
IMUX icon

BVF Inc’s Immunic IMUX Stock Holding History

BVF Inc’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
765,295
-2
-0% -$25 0.3% 35
2026
Q1 		$8.49M Hold
765,297
– – 0.27% 34
2025
Q4 		$4.08M Hold
765,297
– – 0.14% 39
2025
Q3 		$6.75M Hold
765,297
– – 0.27% 37
2025
Q2 		$5.34M Sell
765,297
-125,000
-14% -$1.15M 0.19% 36
2025
Q1 		$9.7M Hold
890,297
– – 0.4% 34
2024
Q4 		$8.9M Hold
890,297
– – 0.3% 39
2024
Q3 		$14.7M Hold
890,297
– – 0.43% 34
2024
Q2 		$9.88M Hold
890,297
– – 0.28% 38
2024
Q1 		$11.8M Buy
+890,297
New +$11.6M 0.32% 39
2023
Q4 		– Sell
-114,943
Closed -$1.69M – 72
2023
Q3 		$1.69M Hold
114,943
– – 0.05% 66
2023
Q2 		$2.89M Hold
114,943
– – 0.08% 60
2023
Q1 		$1.71M Hold
114,943
– – 0.06% 66
2022
Q4 		$1.61M Buy
+114,943
New +$3.13M 0.07% 68

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

BVF Inc's IMUX Position: Q2 2026 in Review

BVF Inc reduced its Immunic (IMUX) stake by 0% in Q2 2026, selling an estimated $25 and leaving 765,295 shares worth $11.8M. The position accounts for 0.3% of the portfolio, ranked #35.

BVF Inc first reported a position in IMUX in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.7M in Q3 2024. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • BVF Inc held 765,295 shares of Immunic worth $11.8M as of Q2 2026.
  • BVF Inc sold 2 Immunic shares in Q2 2026, an estimated $25.
  • Immunic made up 0.3% of BVF Inc's portfolio in Q2 2026, its #35 holding.
  • BVF Inc first reported a position in Immunic in Q4 2022 and has held it in 14 quarters since.
  • BVF Inc's Immunic position peaked at $14.7M in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.